The latest news on the prevention, detection, diagnosis, and prognosis of cancer, and treatment modalities including chemotherapy, surgery, radiotherapy, and hormone therapy.
General oncology
Browse Archive: 
16 September 2014
Combining erlotinib with bevacizumab could prolong progression-free survival in patients being treated for epidermal growth factor receptor-mutated non-small-cell lung cancer, phase II trial results suggest.
08 September 2014
Lower levels of free testosterone predict an increased likelihood of disease reclassification in men with prostate cancer, researchers report.
18 August 2014
There has been a recent increase in use of radiotherapy in Japanese men newly diagnosed with prostate cancer and a concomitant decrease in use of androgen deprivation therapy, study findings indicate.
18 August 2014
Among men with prostate cancer detected on screening, survival among those with a mutation in the BRCA2 gene is much poorer than in those without such a mutation, researchers report.
18 August 2014
Lymphopenia is a significant predictor of outcome in patients undergoing surgery for papillary renal cell carcinoma, US researchers report.
04 August 2014
Japanese researchers have identified certain pelvic anatomic features in men who have undergone radical prostatectomy that are associated with specific lower urinary tract symptoms.
01 August 2014
People with diabetes mellitus have a significantly increased risk of developing head and neck cancer compared with those without the condition, show results of a large study conducted in Taiwan.
22 July 2014
Researchers have identified a population of clear cell renal cell carcinoma cells positive for the CTR2 marker that possess some stem-cell-like features and are able to induce an angiogenic response in vivo. Targeting CTR2 was shown to decrease drug resistance to cisplatin.
Friendly links

Follow me on Twitter